Advanced search
Add to list

In vitro evaluation of Bi-213-rituximab versus external gamma irradiation for the treatment of B-CLL patients: relative biological efficacy with respect to apoptosis induction and chromosomal damage

Author
Organization

Citation

Please use this url to cite or link to this publication:

MLA
Vandenbulcke, Katia, et al. “In Vitro Evaluation of Bi-213-Rituximab versus External Gamma Irradiation for the Treatment of B-CLL Patients: Relative Biological Efficacy with Respect to Apoptosis Induction and Chromosomal Damage.” EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, vol. 30, no. 10, SPRINGER-VERLAG, 2003, pp. 1357–64.
APA
Vandenbulcke, K., De Vos, F., Offner, F., Philippé, J., APOSTOLIDIS, C., MOLINET, R., … Slegers, G. (2003). In vitro evaluation of Bi-213-rituximab versus external gamma irradiation for the treatment of B-CLL patients: relative biological efficacy with respect to apoptosis induction and chromosomal damage. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 30(10), 1357–1364.
Chicago author-date
Vandenbulcke, Katia, Filip De Vos, Fritz Offner, Jan Philippé, C APOSTOLIDIS, R MOLINET, TK NIKULA, et al. 2003. “In Vitro Evaluation of Bi-213-Rituximab versus External Gamma Irradiation for the Treatment of B-CLL Patients: Relative Biological Efficacy with Respect to Apoptosis Induction and Chromosomal Damage.” EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 30 (10): 1357–64.
Chicago author-date (all authors)
Vandenbulcke, Katia, Filip De Vos, Fritz Offner, Jan Philippé, C APOSTOLIDIS, R MOLINET, TK NIKULA, Klaus Bacher, V DE GELDER, Anne Vral, Christophe Lahorte, Hubert Thierens, Rudi Dierckx, and Guido Slegers. 2003. “In Vitro Evaluation of Bi-213-Rituximab versus External Gamma Irradiation for the Treatment of B-CLL Patients: Relative Biological Efficacy with Respect to Apoptosis Induction and Chromosomal Damage.” EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 30 (10): 1357–1364.
Vancouver
1.
Vandenbulcke K, De Vos F, Offner F, Philippé J, APOSTOLIDIS C, MOLINET R, et al. In vitro evaluation of Bi-213-rituximab versus external gamma irradiation for the treatment of B-CLL patients: relative biological efficacy with respect to apoptosis induction and chromosomal damage. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2003;30(10):1357–64.
IEEE
[1]
K. Vandenbulcke et al., “In vitro evaluation of Bi-213-rituximab versus external gamma irradiation for the treatment of B-CLL patients: relative biological efficacy with respect to apoptosis induction and chromosomal damage,” EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, vol. 30, no. 10, pp. 1357–1364, 2003.
@article{215179,
  author       = {{Vandenbulcke, Katia and De Vos, Filip and Offner, Fritz and Philippé, Jan and APOSTOLIDIS, C and MOLINET, R and NIKULA, TK and Bacher, Klaus and DE GELDER, V and Vral, Anne and Lahorte, Christophe and Thierens, Hubert and Dierckx, Rudi and Slegers, Guido}},
  issn         = {{1619-7070}},
  journal      = {{EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING}},
  language     = {{eng}},
  number       = {{10}},
  pages        = {{1357--1364}},
  publisher    = {{SPRINGER-VERLAG}},
  title        = {{In vitro evaluation of Bi-213-rituximab versus external gamma irradiation for the treatment of B-CLL patients: relative biological efficacy with respect to apoptosis induction and chromosomal damage}},
  volume       = {{30}},
  year         = {{2003}},
}

Web of Science
Times cited: